nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Amitriptyline—migraine	0.508	1	CrCtD
Doxylamine—CHRM1—Amitriptyline—migraine	0.0594	0.543	CbGbCtD
Doxylamine—HRH1—Amitriptyline—migraine	0.05	0.457	CbGbCtD
Doxylamine—Doxepin—Amitriptyline—migraine	0.0312	0.107	CrCrCtD
Doxylamine—Cyclobenzaprine—Amitriptyline—migraine	0.0294	0.101	CrCrCtD
Doxylamine—Dimetindene—Amitriptyline—migraine	0.0285	0.0977	CrCrCtD
Doxylamine—Tripelennamine—Amitriptyline—migraine	0.0244	0.0836	CrCrCtD
Doxylamine—Dimetacrine—Amitriptyline—migraine	0.0228	0.0782	CrCrCtD
Doxylamine—Bromodiphenhydramine—Amitriptyline—migraine	0.0228	0.0782	CrCrCtD
Doxylamine—Pheniramine—Amitriptyline—migraine	0.0223	0.0765	CrCrCtD
Doxylamine—Imipramine—Amitriptyline—migraine	0.0219	0.0749	CrCrCtD
Doxylamine—Atomoxetine—Propranolol—migraine	0.019	0.0651	CrCrCtD
Doxylamine—Clofedanol—Amitriptyline—migraine	0.0185	0.0635	CrCrCtD
Doxylamine—Orphenadrine—Amitriptyline—migraine	0.0179	0.0614	CrCrCtD
Doxylamine—Promazine—Amitriptyline—migraine	0.0171	0.0586	CrCrCtD
Doxylamine—Diphenhydramine—Amitriptyline—migraine	0.0159	0.0546	CrCrCtD
Doxylamine—HRH1—Monoamine GPCRs—HTR1D—migraine	0.000735	0.0325	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR1D—migraine	0.000733	0.0324	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR2B—migraine	0.000683	0.0302	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR2B—migraine	0.000681	0.0301	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR1D—migraine	0.000618	0.0273	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR1D—migraine	0.000616	0.0272	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR2B—migraine	0.000574	0.0254	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR2B—migraine	0.000572	0.0253	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR1B—migraine	0.000445	0.0197	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR1B—migraine	0.000444	0.0196	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR1A—migraine	0.000429	0.0189	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR1A—migraine	0.000427	0.0189	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR2C—migraine	0.000414	0.0183	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR2C—migraine	0.000413	0.0182	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR1B—migraine	0.000374	0.0165	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR1B—migraine	0.000373	0.0165	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR7—migraine	0.000363	0.016	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR7—migraine	0.000361	0.016	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR1A—migraine	0.00036	0.0159	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR1A—migraine	0.000359	0.0159	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR2C—migraine	0.000348	0.0154	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR2C—migraine	0.000347	0.0153	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR7—migraine	0.000305	0.0135	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR7—migraine	0.000304	0.0134	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR2A—migraine	0.000254	0.0112	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR2A—migraine	0.000253	0.0112	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000229	0.0101	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR2A—migraine	0.000213	0.00944	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR2A—migraine	0.000213	0.00941	CbGpPWpGaD
Doxylamine—Atomoxetine—HTR1D—migraine	0.000188	0.076	CrCbGaD
Doxylamine—Toremifene—ESR1—migraine	0.000175	0.0708	CrCbGaD
Doxylamine—Orphenadrine—SCN1A—migraine	0.000173	0.0702	CrCbGaD
Doxylamine—HRH1—G alpha (q) signalling events—HTR2B—migraine	0.000171	0.00754	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—HTR2B—migraine	0.00017	0.00752	CbGpPWpGaD
Doxylamine—Confusional state—Verapamil—migraine	0.000163	0.00249	CcSEcCtD
Doxylamine—Sweating increased—Gabapentin—migraine	0.000163	0.00249	CcSEcCtD
Doxylamine—Diplopia—Topiramate—migraine	0.000163	0.00249	CcSEcCtD
Doxylamine—Anaphylactic shock—Verapamil—migraine	0.000162	0.00247	CcSEcCtD
Doxylamine—Hallucination—Valproic Acid—migraine	0.00016	0.00245	CcSEcCtD
Doxylamine—Affect lability—Topiramate—migraine	0.00016	0.00245	CcSEcCtD
Doxylamine—Depression—Timolol—migraine	0.000159	0.00244	CcSEcCtD
Doxylamine—Urinary tract disorder—Valproic Acid—migraine	0.000159	0.00244	CcSEcCtD
Doxylamine—Insomnia—Propranolol—migraine	0.000159	0.00243	CcSEcCtD
Doxylamine—Urethral disorder—Valproic Acid—migraine	0.000158	0.00242	CcSEcCtD
Doxylamine—Tachycardia—Verapamil—migraine	0.000158	0.00241	CcSEcCtD
Doxylamine—Dyspnoea—Propranolol—migraine	0.000157	0.00239	CcSEcCtD
Doxylamine—Hyperhidrosis—Verapamil—migraine	0.000156	0.00239	CcSEcCtD
Doxylamine—Somnolence—Propranolol—migraine	0.000156	0.00239	CcSEcCtD
Doxylamine—Irritability—Topiramate—migraine	0.000155	0.00237	CcSEcCtD
Doxylamine—Asthenia—Amitriptyline—migraine	0.000155	0.00237	CcSEcCtD
Doxylamine—Urinary retention—Topiramate—migraine	0.000155	0.00236	CcSEcCtD
Doxylamine—Mood swings—Topiramate—migraine	0.000154	0.00236	CcSEcCtD
Doxylamine—Sweating—Timolol—migraine	0.000153	0.00234	CcSEcCtD
Doxylamine—Decreased appetite—Propranolol—migraine	0.000153	0.00233	CcSEcCtD
Doxylamine—Pruritus—Amitriptyline—migraine	0.000153	0.00233	CcSEcCtD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000153	0.00674	CbGpPWpGaD
Doxylamine—Erythema multiforme—Valproic Acid—migraine	0.000152	0.00233	CcSEcCtD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000152	0.00672	CbGpPWpGaD
Doxylamine—Gastrointestinal disorder—Propranolol—migraine	0.000152	0.00232	CcSEcCtD
Doxylamine—Fatigue—Propranolol—migraine	0.000151	0.00232	CcSEcCtD
Doxylamine—Dehydration—Topiramate—migraine	0.000151	0.00231	CcSEcCtD
Doxylamine—Hypotension—Verapamil—migraine	0.000151	0.00231	CcSEcCtD
Doxylamine—Eye disorder—Valproic Acid—migraine	0.000151	0.0023	CcSEcCtD
Doxylamine—Constipation—Propranolol—migraine	0.00015	0.0023	CcSEcCtD
Doxylamine—Agranulocytosis—Timolol—migraine	0.000149	0.00228	CcSEcCtD
Doxylamine—Drowsiness—Gabapentin—migraine	0.000149	0.00228	CcSEcCtD
Doxylamine—Depression—Gabapentin—migraine	0.000148	0.00227	CcSEcCtD
Doxylamine—Orthostatic hypotension—Topiramate—migraine	0.000148	0.00227	CcSEcCtD
Doxylamine—Methadone—HTR3A—migraine	0.000148	0.0599	CrCbGaD
Doxylamine—Stevens-Johnson syndrome—Gabapentin—migraine	0.000148	0.00226	CcSEcCtD
Doxylamine—Diarrhoea—Amitriptyline—migraine	0.000148	0.00226	CcSEcCtD
Doxylamine—Breast disorder—Topiramate—migraine	0.000147	0.00225	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Topiramate—migraine	0.000146	0.00224	CcSEcCtD
Doxylamine—Insomnia—Verapamil—migraine	0.000146	0.00223	CcSEcCtD
Doxylamine—Bradycardia—Timolol—migraine	0.000146	0.00223	CcSEcCtD
Doxylamine—Immune system disorder—Valproic Acid—migraine	0.000146	0.00223	CcSEcCtD
Doxylamine—Doxepin—HTR2B—migraine	0.000146	0.0589	CrCbGaD
Doxylamine—Nasopharyngitis—Topiramate—migraine	0.000145	0.00222	CcSEcCtD
Doxylamine—Mediastinal disorder—Valproic Acid—migraine	0.000145	0.00222	CcSEcCtD
Doxylamine—Dyspnoea—Verapamil—migraine	0.000144	0.0022	CcSEcCtD
Doxylamine—Somnolence—Verapamil—migraine	0.000144	0.0022	CcSEcCtD
Doxylamine—Hallucination—Timolol—migraine	0.000143	0.00218	CcSEcCtD
Doxylamine—Sweating—Gabapentin—migraine	0.000143	0.00218	CcSEcCtD
Doxylamine—Dizziness—Amitriptyline—migraine	0.000143	0.00218	CcSEcCtD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000142	0.00627	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000141	0.00625	CbGpPWpGaD
Doxylamine—Urticaria—Propranolol—migraine	0.00014	0.00213	CcSEcCtD
Doxylamine—Fatigue—Verapamil—migraine	0.000139	0.00213	CcSEcCtD
Doxylamine—Constipation—Verapamil—migraine	0.000138	0.00211	CcSEcCtD
Doxylamine—Pancreatitis—Topiramate—migraine	0.000138	0.00211	CcSEcCtD
Doxylamine—Vomiting—Amitriptyline—migraine	0.000137	0.0021	CcSEcCtD
Doxylamine—HRH1—IL-4 Signaling Pathway—FOS—migraine	0.000137	0.00606	CbGpPWpGaD
Doxylamine—Sweating increased—Topiramate—migraine	0.000137	0.00209	CcSEcCtD
Doxylamine—Bradycardia—Gabapentin—migraine	0.000136	0.00208	CcSEcCtD
Doxylamine—Rash—Amitriptyline—migraine	0.000136	0.00208	CcSEcCtD
Doxylamine—Dermatitis—Amitriptyline—migraine	0.000136	0.00208	CcSEcCtD
Doxylamine—Muscle spasms—Valproic Acid—migraine	0.000135	0.00206	CcSEcCtD
Doxylamine—Abdominal discomfort—Topiramate—migraine	0.000135	0.00206	CcSEcCtD
Doxylamine—Eye disorder—Timolol—migraine	0.000134	0.00205	CcSEcCtD
Doxylamine—Hepatitis—Gabapentin—migraine	0.000134	0.00204	CcSEcCtD
Doxylamine—Pancytopenia—Topiramate—migraine	0.000133	0.00204	CcSEcCtD
Doxylamine—Cardiac disorder—Timolol—migraine	0.000133	0.00204	CcSEcCtD
Doxylamine—Feeling abnormal—Verapamil—migraine	0.000133	0.00204	CcSEcCtD
Doxylamine—Hallucination—Gabapentin—migraine	0.000133	0.00203	CcSEcCtD
Doxylamine—Urinary tract disorder—Gabapentin—migraine	0.000132	0.00202	CcSEcCtD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000132	0.00583	CbGpPWpGaD
Doxylamine—Tremor—Valproic Acid—migraine	0.000131	0.00201	CcSEcCtD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000131	0.00581	CbGpPWpGaD
Doxylamine—Urethral disorder—Gabapentin—migraine	0.000131	0.002	CcSEcCtD
Doxylamine—Ill-defined disorder—Valproic Acid—migraine	0.00013	0.00199	CcSEcCtD
Doxylamine—Immune system disorder—Timolol—migraine	0.00013	0.00198	CcSEcCtD
Doxylamine—Hypersensitivity—Propranolol—migraine	0.000129	0.00198	CcSEcCtD
Doxylamine—Mediastinal disorder—Timolol—migraine	0.000129	0.00198	CcSEcCtD
Doxylamine—Agitation—Valproic Acid—migraine	0.000129	0.00197	CcSEcCtD
Doxylamine—Urticaria—Verapamil—migraine	0.000128	0.00196	CcSEcCtD
Doxylamine—Angioedema—Valproic Acid—migraine	0.000128	0.00196	CcSEcCtD
Doxylamine—Nausea—Amitriptyline—migraine	0.000128	0.00196	CcSEcCtD
Doxylamine—HRH1—GPCR ligand binding—RAMP1—migraine	0.000127	0.00563	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CALCRL—migraine	0.000127	0.00563	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—RAMP1—migraine	0.000127	0.00561	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CALCRL—migraine	0.000127	0.00561	CbGpPWpGaD
Doxylamine—Malaise—Valproic Acid—migraine	0.000127	0.00194	CcSEcCtD
Doxylamine—Erythema multiforme—Gabapentin—migraine	0.000126	0.00193	CcSEcCtD
Doxylamine—Vertigo—Valproic Acid—migraine	0.000126	0.00193	CcSEcCtD
Doxylamine—Asthenia—Propranolol—migraine	0.000126	0.00193	CcSEcCtD
Doxylamine—Leukopenia—Valproic Acid—migraine	0.000126	0.00192	CcSEcCtD
Doxylamine—Erythema—Timolol—migraine	0.000125	0.00191	CcSEcCtD
Doxylamine—Eye disorder—Gabapentin—migraine	0.000125	0.00191	CcSEcCtD
Doxylamine—Depression—Topiramate—migraine	0.000125	0.00191	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Topiramate—migraine	0.000124	0.0019	CcSEcCtD
Doxylamine—Cardiac disorder—Gabapentin—migraine	0.000124	0.0019	CcSEcCtD
Doxylamine—Palpitations—Valproic Acid—migraine	0.000124	0.0019	CcSEcCtD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000122	0.00537	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000121	0.00535	CbGpPWpGaD
Doxylamine—Immune system disorder—Gabapentin—migraine	0.000121	0.00185	CcSEcCtD
Doxylamine—Mediastinal disorder—Gabapentin—migraine	0.00012	0.00184	CcSEcCtD
Doxylamine—Diarrhoea—Propranolol—migraine	0.00012	0.00184	CcSEcCtD
Doxylamine—Anxiety—Valproic Acid—migraine	0.000119	0.00182	CcSEcCtD
Doxylamine—Hypersensitivity—Verapamil—migraine	0.000119	0.00182	CcSEcCtD
Doxylamine—Discomfort—Valproic Acid—migraine	0.000118	0.00181	CcSEcCtD
Doxylamine—Agranulocytosis—Topiramate—migraine	0.000117	0.00179	CcSEcCtD
Doxylamine—Dry mouth—Valproic Acid—migraine	0.000117	0.00179	CcSEcCtD
Doxylamine—Erythema—Gabapentin—migraine	0.000116	0.00178	CcSEcCtD
Doxylamine—Dizziness—Propranolol—migraine	0.000116	0.00178	CcSEcCtD
Doxylamine—Asthenia—Verapamil—migraine	0.000116	0.00177	CcSEcCtD
Doxylamine—Confusional state—Valproic Acid—migraine	0.000115	0.00177	CcSEcCtD
Doxylamine—Anaphylactic shock—Valproic Acid—migraine	0.000115	0.00175	CcSEcCtD
Doxylamine—Bradycardia—Topiramate—migraine	0.000114	0.00175	CcSEcCtD
Doxylamine—Pruritus—Verapamil—migraine	0.000114	0.00175	CcSEcCtD
Doxylamine—Angioedema—Timolol—migraine	0.000114	0.00175	CcSEcCtD
Doxylamine—Amitriptyline—HTR1D—migraine	0.000114	0.046	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000113	0.00499	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000113	0.00498	CbGpPWpGaD
Doxylamine—Hepatitis—Topiramate—migraine	0.000112	0.00172	CcSEcCtD
Doxylamine—Nervous system disorder—Valproic Acid—migraine	0.000112	0.00172	CcSEcCtD
Doxylamine—Vertigo—Timolol—migraine	0.000112	0.00172	CcSEcCtD
Doxylamine—Thrombocytopenia—Valproic Acid—migraine	0.000112	0.00172	CcSEcCtD
Doxylamine—Hallucination—Topiramate—migraine	0.000112	0.00171	CcSEcCtD
Doxylamine—Muscle spasms—Gabapentin—migraine	0.000112	0.00171	CcSEcCtD
Doxylamine—Tachycardia—Valproic Acid—migraine	0.000112	0.00171	CcSEcCtD
Doxylamine—Vomiting—Propranolol—migraine	0.000112	0.00171	CcSEcCtD
Doxylamine—Atomoxetine—HTR1B—migraine	0.000111	0.0451	CrCbGaD
Doxylamine—Urinary tract disorder—Topiramate—migraine	0.000111	0.0017	CcSEcCtD
Doxylamine—Hyperhidrosis—Valproic Acid—migraine	0.000111	0.00169	CcSEcCtD
Doxylamine—Rash—Propranolol—migraine	0.000111	0.00169	CcSEcCtD
Doxylamine—Dermatitis—Propranolol—migraine	0.000111	0.00169	CcSEcCtD
Doxylamine—Diarrhoea—Verapamil—migraine	0.000111	0.00169	CcSEcCtD
Doxylamine—Palpitations—Timolol—migraine	0.00011	0.00169	CcSEcCtD
Doxylamine—Urethral disorder—Topiramate—migraine	0.00011	0.00169	CcSEcCtD
Doxylamine—Anorexia—Valproic Acid—migraine	0.000109	0.00167	CcSEcCtD
Doxylamine—Tremor—Gabapentin—migraine	0.000109	0.00167	CcSEcCtD
Doxylamine—Ill-defined disorder—Gabapentin—migraine	0.000108	0.00165	CcSEcCtD
Doxylamine—Hypotension—Valproic Acid—migraine	0.000107	0.00164	CcSEcCtD
Doxylamine—Agitation—Gabapentin—migraine	0.000107	0.00164	CcSEcCtD
Doxylamine—Dizziness—Verapamil—migraine	0.000107	0.00163	CcSEcCtD
Doxylamine—Erythema multiforme—Topiramate—migraine	0.000106	0.00163	CcSEcCtD
Doxylamine—Angioedema—Gabapentin—migraine	0.000106	0.00163	CcSEcCtD
Doxylamine—Anxiety—Timolol—migraine	0.000106	0.00162	CcSEcCtD
Doxylamine—HRH1—G alpha (q) signalling events—NPS—migraine	0.000105	0.00466	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—TAC1—migraine	0.000105	0.00466	CbGpPWpGaD
Doxylamine—Discomfort—Timolol—migraine	0.000105	0.00161	CcSEcCtD
Doxylamine—Eye disorder—Topiramate—migraine	0.000105	0.00161	CcSEcCtD
Doxylamine—CHRM1—G alpha (q) signalling events—NPS—migraine	0.000105	0.00464	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—TAC1—migraine	0.000105	0.00464	CbGpPWpGaD
Doxylamine—Malaise—Gabapentin—migraine	0.000105	0.0016	CcSEcCtD
Doxylamine—Vertigo—Gabapentin—migraine	0.000105	0.0016	CcSEcCtD
Doxylamine—Cardiac disorder—Topiramate—migraine	0.000104	0.0016	CcSEcCtD
Doxylamine—Flushing—Topiramate—migraine	0.000104	0.0016	CcSEcCtD
Doxylamine—Nausea—Propranolol—migraine	0.000104	0.0016	CcSEcCtD
Doxylamine—Leukopenia—Gabapentin—migraine	0.000104	0.00159	CcSEcCtD
Doxylamine—Dry mouth—Timolol—migraine	0.000104	0.00159	CcSEcCtD
Doxylamine—Insomnia—Valproic Acid—migraine	0.000104	0.00158	CcSEcCtD
Doxylamine—HRH1—G alpha (q) signalling events—HTR2C—migraine	0.000103	0.00457	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—HTR2C—migraine	0.000103	0.00455	CbGpPWpGaD
Doxylamine—Palpitations—Gabapentin—migraine	0.000103	0.00157	CcSEcCtD
Doxylamine—Confusional state—Timolol—migraine	0.000103	0.00157	CcSEcCtD
Doxylamine—Vomiting—Verapamil—migraine	0.000103	0.00157	CcSEcCtD
Doxylamine—Dyspnoea—Valproic Acid—migraine	0.000102	0.00156	CcSEcCtD
Doxylamine—Anaphylactic shock—Timolol—migraine	0.000102	0.00156	CcSEcCtD
Doxylamine—Rash—Verapamil—migraine	0.000102	0.00156	CcSEcCtD
Doxylamine—Somnolence—Valproic Acid—migraine	0.000102	0.00156	CcSEcCtD
Doxylamine—Dermatitis—Verapamil—migraine	0.000102	0.00156	CcSEcCtD
Doxylamine—Immune system disorder—Topiramate—migraine	0.000102	0.00155	CcSEcCtD
Doxylamine—Mediastinal disorder—Topiramate—migraine	0.000101	0.00155	CcSEcCtD
Doxylamine—Convulsion—Gabapentin—migraine	0.000101	0.00154	CcSEcCtD
Doxylamine—HRH1—G alpha (q) signalling events—EDNRA—migraine	0.000101	0.00444	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—EDNRA—migraine	0.0001	0.00443	CbGpPWpGaD
Doxylamine—Nervous system disorder—Timolol—migraine	0.0001	0.00153	CcSEcCtD
Doxylamine—Decreased appetite—Valproic Acid—migraine	9.96e-05	0.00152	CcSEcCtD
Doxylamine—CHRM1—Circadian rythm related genes—NPS—migraine	9.91e-05	0.00438	CbGpPWpGaD
Doxylamine—Gastrointestinal disorder—Valproic Acid—migraine	9.89e-05	0.00151	CcSEcCtD
Doxylamine—Fatigue—Valproic Acid—migraine	9.88e-05	0.00151	CcSEcCtD
Doxylamine—Anxiety—Gabapentin—migraine	9.87e-05	0.00151	CcSEcCtD
Doxylamine—Hyperhidrosis—Timolol—migraine	9.86e-05	0.00151	CcSEcCtD
Doxylamine—Cyclobenzaprine—HTR2A—migraine	9.83e-05	0.0398	CrCbGaD
Doxylamine—Constipation—Valproic Acid—migraine	9.8e-05	0.0015	CcSEcCtD
Doxylamine—Erythema—Topiramate—migraine	9.79e-05	0.0015	CcSEcCtD
Doxylamine—Discomfort—Gabapentin—migraine	9.79e-05	0.0015	CcSEcCtD
Doxylamine—CHRM1—Circadian rythm related genes—SLC6A4—migraine	9.72e-05	0.0043	CbGpPWpGaD
Doxylamine—Anorexia—Timolol—migraine	9.72e-05	0.00149	CcSEcCtD
Doxylamine—Dry mouth—Gabapentin—migraine	9.69e-05	0.00148	CcSEcCtD
Doxylamine—Nausea—Verapamil—migraine	9.6e-05	0.00147	CcSEcCtD
Doxylamine—Confusional state—Gabapentin—migraine	9.57e-05	0.00146	CcSEcCtD
Doxylamine—Hypotension—Timolol—migraine	9.53e-05	0.00146	CcSEcCtD
Doxylamine—Anaphylactic shock—Gabapentin—migraine	9.5e-05	0.00145	CcSEcCtD
Doxylamine—Feeling abnormal—Valproic Acid—migraine	9.44e-05	0.00144	CcSEcCtD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	9.42e-05	0.00417	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	9.42e-05	0.00417	CbGpPWpGaD
Doxylamine—Muscle spasms—Topiramate—migraine	9.41e-05	0.00144	CcSEcCtD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	9.39e-05	0.00415	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	9.39e-05	0.00415	CbGpPWpGaD
Doxylamine—Nervous system disorder—Gabapentin—migraine	9.31e-05	0.00142	CcSEcCtD
Doxylamine—Thrombocytopenia—Gabapentin—migraine	9.3e-05	0.00142	CcSEcCtD
Doxylamine—Tachycardia—Gabapentin—migraine	9.27e-05	0.00142	CcSEcCtD
Doxylamine—HRH1—GPCR ligand binding—HTR1D—migraine	9.25e-05	0.00409	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	9.24e-05	0.00409	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR1D—migraine	9.22e-05	0.00408	CbGpPWpGaD
Doxylamine—Insomnia—Timolol—migraine	9.22e-05	0.00141	CcSEcCtD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	9.21e-05	0.00407	CbGpPWpGaD
Doxylamine—Hyperhidrosis—Gabapentin—migraine	9.18e-05	0.0014	CcSEcCtD
Doxylamine—Tremor—Topiramate—migraine	9.17e-05	0.0014	CcSEcCtD
Doxylamine—Urticaria—Valproic Acid—migraine	9.1e-05	0.00139	CcSEcCtD
Doxylamine—Dyspnoea—Timolol—migraine	9.09e-05	0.00139	CcSEcCtD
Doxylamine—Ill-defined disorder—Topiramate—migraine	9.08e-05	0.00139	CcSEcCtD
Doxylamine—Atomoxetine—HTR2C—migraine	9.07e-05	0.0367	CrCbGaD
Doxylamine—Somnolence—Timolol—migraine	9.07e-05	0.00139	CcSEcCtD
Doxylamine—Anorexia—Gabapentin—migraine	9.05e-05	0.00138	CcSEcCtD
Doxylamine—Agitation—Topiramate—migraine	9e-05	0.00138	CcSEcCtD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	8.99e-05	0.00398	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	8.96e-05	0.00396	CbGpPWpGaD
Doxylamine—Chlorphenamine—SLC6A4—migraine	8.95e-05	0.0362	CrCbGaD
Doxylamine—Hypotension—Gabapentin—migraine	8.87e-05	0.00136	CcSEcCtD
Doxylamine—Decreased appetite—Timolol—migraine	8.86e-05	0.00136	CcSEcCtD
Doxylamine—Malaise—Topiramate—migraine	8.83e-05	0.00135	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Timolol—migraine	8.8e-05	0.00135	CcSEcCtD
Doxylamine—Vertigo—Topiramate—migraine	8.79e-05	0.00135	CcSEcCtD
Doxylamine—Fatigue—Timolol—migraine	8.79e-05	0.00134	CcSEcCtD
Doxylamine—Leukopenia—Topiramate—migraine	8.76e-05	0.00134	CcSEcCtD
Doxylamine—Palpitations—Topiramate—migraine	8.65e-05	0.00132	CcSEcCtD
Doxylamine—HRH1—GPCR ligand binding—HTR2B—migraine	8.6e-05	0.0038	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	8.59e-05	0.0038	CbGpPWpGaD
Doxylamine—Insomnia—Gabapentin—migraine	8.59e-05	0.00131	CcSEcCtD
Doxylamine—CHRM1—GPCR ligand binding—HTR2B—migraine	8.57e-05	0.00379	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	8.56e-05	0.00379	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—HTR7—migraine	8.52e-05	0.00377	CbGpPWpGaD
Doxylamine—Convulsion—Topiramate—migraine	8.48e-05	0.0013	CcSEcCtD
Doxylamine—Dyspnoea—Gabapentin—migraine	8.47e-05	0.00129	CcSEcCtD
Doxylamine—Somnolence—Gabapentin—migraine	8.44e-05	0.00129	CcSEcCtD
Doxylamine—Hypersensitivity—Valproic Acid—migraine	8.44e-05	0.00129	CcSEcCtD
Doxylamine—Feeling abnormal—Timolol—migraine	8.4e-05	0.00129	CcSEcCtD
Doxylamine—Anxiety—Topiramate—migraine	8.3e-05	0.00127	CcSEcCtD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.27e-05	0.00366	CbGpPWpGaD
Doxylamine—Decreased appetite—Gabapentin—migraine	8.25e-05	0.00126	CcSEcCtD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.24e-05	0.00365	CbGpPWpGaD
Doxylamine—Discomfort—Topiramate—migraine	8.23e-05	0.00126	CcSEcCtD
Doxylamine—Asthenia—Valproic Acid—migraine	8.22e-05	0.00126	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Gabapentin—migraine	8.2e-05	0.00125	CcSEcCtD
Doxylamine—Fatigue—Gabapentin—migraine	8.19e-05	0.00125	CcSEcCtD
Doxylamine—Dry mouth—Topiramate—migraine	8.15e-05	0.00125	CcSEcCtD
Doxylamine—Constipation—Gabapentin—migraine	8.12e-05	0.00124	CcSEcCtD
Doxylamine—Pruritus—Valproic Acid—migraine	8.1e-05	0.00124	CcSEcCtD
Doxylamine—Urticaria—Timolol—migraine	8.1e-05	0.00124	CcSEcCtD
Doxylamine—Confusional state—Topiramate—migraine	8.06e-05	0.00123	CcSEcCtD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	7.99e-05	0.00353	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	7.96e-05	0.00352	CbGpPWpGaD
Doxylamine—Diarrhoea—Valproic Acid—migraine	7.84e-05	0.0012	CcSEcCtD
Doxylamine—Nervous system disorder—Topiramate—migraine	7.83e-05	0.0012	CcSEcCtD
Doxylamine—Feeling abnormal—Gabapentin—migraine	7.83e-05	0.0012	CcSEcCtD
Doxylamine—Thrombocytopenia—Topiramate—migraine	7.82e-05	0.0012	CcSEcCtD
Doxylamine—Tachycardia—Topiramate—migraine	7.8e-05	0.00119	CcSEcCtD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.77e-05	0.00344	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.75e-05	0.00342	CbGpPWpGaD
Doxylamine—Hyperhidrosis—Topiramate—migraine	7.72e-05	0.00118	CcSEcCtD
Doxylamine—Anorexia—Topiramate—migraine	7.62e-05	0.00116	CcSEcCtD
Doxylamine—Dizziness—Valproic Acid—migraine	7.57e-05	0.00116	CcSEcCtD
Doxylamine—Urticaria—Gabapentin—migraine	7.54e-05	0.00115	CcSEcCtD
Doxylamine—Atomoxetine—SLC6A4—migraine	7.52e-05	0.0304	CrCbGaD
Doxylamine—Hypersensitivity—Timolol—migraine	7.51e-05	0.00115	CcSEcCtD
Doxylamine—Hypotension—Topiramate—migraine	7.47e-05	0.00114	CcSEcCtD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.36e-05	0.00325	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.34e-05	0.00324	CbGpPWpGaD
Doxylamine—Asthenia—Timolol—migraine	7.32e-05	0.00112	CcSEcCtD
Doxylamine—Vomiting—Valproic Acid—migraine	7.28e-05	0.00111	CcSEcCtD
Doxylamine—Insomnia—Topiramate—migraine	7.23e-05	0.00111	CcSEcCtD
Doxylamine—Rash—Valproic Acid—migraine	7.22e-05	0.0011	CcSEcCtD
Doxylamine—Dermatitis—Valproic Acid—migraine	7.22e-05	0.0011	CcSEcCtD
Doxylamine—Pruritus—Timolol—migraine	7.21e-05	0.0011	CcSEcCtD
Doxylamine—HRH1—GPCR downstream signaling—CALCRL—migraine	7.2e-05	0.00318	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—RAMP1—migraine	7.2e-05	0.00318	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CALCRL—migraine	7.17e-05	0.00317	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—RAMP1—migraine	7.17e-05	0.00317	CbGpPWpGaD
Doxylamine—Dyspnoea—Topiramate—migraine	7.12e-05	0.00109	CcSEcCtD
Doxylamine—Doxepin—HTR2C—migraine	7.11e-05	0.0288	CrCbGaD
Doxylamine—Somnolence—Topiramate—migraine	7.1e-05	0.00109	CcSEcCtD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.09e-05	0.00313	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.06e-05	0.00312	CbGpPWpGaD
Doxylamine—Imipramine—HTR7—migraine	7.01e-05	0.0284	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7e-05	0.00309	CbGpPWpGaD
Doxylamine—Hypersensitivity—Gabapentin—migraine	7e-05	0.00107	CcSEcCtD
Doxylamine—Tamoxifen—ESR1—migraine	6.98e-05	0.0283	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.98e-05	0.00309	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.98e-05	0.00309	CbGpPWpGaD
Doxylamine—Diarrhoea—Timolol—migraine	6.98e-05	0.00107	CcSEcCtD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	6.97e-05	0.00308	CbGpPWpGaD
Doxylamine—Amitriptyline—HTR7—migraine	6.97e-05	0.0282	CrCbGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.96e-05	0.00308	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.96e-05	0.00308	CbGpPWpGaD
Doxylamine—Decreased appetite—Topiramate—migraine	6.94e-05	0.00106	CcSEcCtD
Doxylamine—Doxepin—HTR1A—migraine	6.9e-05	0.028	CrCbGaD
Doxylamine—Gastrointestinal disorder—Topiramate—migraine	6.9e-05	0.00105	CcSEcCtD
Doxylamine—Fatigue—Topiramate—migraine	6.89e-05	0.00105	CcSEcCtD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.84e-05	0.00303	CbGpPWpGaD
Doxylamine—Constipation—Topiramate—migraine	6.83e-05	0.00104	CcSEcCtD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.82e-05	0.00302	CbGpPWpGaD
Doxylamine—Asthenia—Gabapentin—migraine	6.81e-05	0.00104	CcSEcCtD
Doxylamine—Nausea—Valproic Acid—migraine	6.8e-05	0.00104	CcSEcCtD
Doxylamine—Amitriptyline—HTR1B—migraine	6.75e-05	0.0273	CrCbGaD
Doxylamine—Dizziness—Timolol—migraine	6.74e-05	0.00103	CcSEcCtD
Doxylamine—Pruritus—Gabapentin—migraine	6.72e-05	0.00103	CcSEcCtD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.66e-05	0.00294	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.64e-05	0.00293	CbGpPWpGaD
Doxylamine—Feeling abnormal—Topiramate—migraine	6.58e-05	0.00101	CcSEcCtD
Doxylamine—HRH1—Signaling by GPCR—RAMP1—migraine	6.53e-05	0.00289	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CALCRL—migraine	6.53e-05	0.00289	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—RAMP1—migraine	6.51e-05	0.00288	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CALCRL—migraine	6.51e-05	0.00288	CbGpPWpGaD
Doxylamine—Diarrhoea—Gabapentin—migraine	6.5e-05	0.000994	CcSEcCtD
Doxylamine—Vomiting—Timolol—migraine	6.48e-05	0.000992	CcSEcCtD
Doxylamine—Rash—Timolol—migraine	6.43e-05	0.000983	CcSEcCtD
Doxylamine—Dermatitis—Timolol—migraine	6.42e-05	0.000982	CcSEcCtD
Doxylamine—Urticaria—Topiramate—migraine	6.35e-05	0.000971	CcSEcCtD
Doxylamine—HRH1—G alpha (q) signalling events—HTR2A—migraine	6.34e-05	0.0028	CbGpPWpGaD
Doxylamine—Promazine—HTR2C—migraine	6.32e-05	0.0256	CrCbGaD
Doxylamine—CHRM1—G alpha (q) signalling events—HTR2A—migraine	6.32e-05	0.00279	CbGpPWpGaD
Doxylamine—Dizziness—Gabapentin—migraine	6.28e-05	0.00096	CcSEcCtD
Doxylamine—Nausea—Timolol—migraine	6.06e-05	0.000926	CcSEcCtD
Doxylamine—Vomiting—Gabapentin—migraine	6.04e-05	0.000923	CcSEcCtD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.99e-05	0.00265	CbGpPWpGaD
Doxylamine—Rash—Gabapentin—migraine	5.99e-05	0.000916	CcSEcCtD
Doxylamine—Dermatitis—Gabapentin—migraine	5.98e-05	0.000915	CcSEcCtD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.97e-05	0.00264	CbGpPWpGaD
Doxylamine—Doxepin—SLC6A4—migraine	5.89e-05	0.0239	CrCbGaD
Doxylamine—Hypersensitivity—Topiramate—migraine	5.89e-05	0.0009	CcSEcCtD
Doxylamine—Atomoxetine—HTR2A—migraine	5.78e-05	0.0234	CrCbGaD
Doxylamine—Asthenia—Topiramate—migraine	5.73e-05	0.000877	CcSEcCtD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	5.67e-05	0.00251	CbGpPWpGaD
Doxylamine—Pruritus—Topiramate—migraine	5.65e-05	0.000864	CcSEcCtD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	5.65e-05	0.0025	CbGpPWpGaD
Doxylamine—Nausea—Gabapentin—migraine	5.64e-05	0.000863	CcSEcCtD
Doxylamine—HRH1—GPCR ligand binding—HTR1B—migraine	5.61e-05	0.00248	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR1B—migraine	5.59e-05	0.00247	CbGpPWpGaD
Doxylamine—Imipramine—HTR2C—migraine	5.53e-05	0.0224	CrCbGaD
Doxylamine—Amitriptyline—HTR2C—migraine	5.5e-05	0.0223	CrCbGaD
Doxylamine—Diarrhoea—Topiramate—migraine	5.47e-05	0.000836	CcSEcCtD
Doxylamine—HRH1—GPCR ligand binding—HTR1A—migraine	5.4e-05	0.00239	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR1A—migraine	5.38e-05	0.00238	CbGpPWpGaD
Doxylamine—Imipramine—HTR1A—migraine	5.37e-05	0.0218	CrCbGaD
Doxylamine—Amitriptyline—HTR1A—migraine	5.34e-05	0.0216	CrCbGaD
Doxylamine—HRH1—GPCR ligand binding—TAC1—migraine	5.31e-05	0.00235	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—NPS—migraine	5.31e-05	0.00235	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—TAC1—migraine	5.3e-05	0.00234	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—NPS—migraine	5.3e-05	0.00234	CbGpPWpGaD
Doxylamine—Dizziness—Topiramate—migraine	5.28e-05	0.000808	CcSEcCtD
Doxylamine—HRH1—GPCR downstream signaling—HTR1D—migraine	5.23e-05	0.00231	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR1D—migraine	5.21e-05	0.0023	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HTR2C—migraine	5.21e-05	0.0023	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR2C—migraine	5.19e-05	0.0023	CbGpPWpGaD
Doxylamine—Vomiting—Topiramate—migraine	5.08e-05	0.000777	CcSEcCtD
Doxylamine—HRH1—GPCR ligand binding—EDNRA—migraine	5.07e-05	0.00224	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—EDNRA—migraine	5.05e-05	0.00223	CbGpPWpGaD
Doxylamine—Rash—Topiramate—migraine	5.04e-05	0.00077	CcSEcCtD
Doxylamine—Dermatitis—Topiramate—migraine	5.03e-05	0.00077	CcSEcCtD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.9e-05	0.00217	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.88e-05	0.00216	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CALCA—migraine	4.88e-05	0.00216	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CALCA—migraine	4.86e-05	0.00215	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2B—migraine	4.86e-05	0.00215	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2B—migraine	4.85e-05	0.00214	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR1D—migraine	4.75e-05	0.0021	CbGpPWpGaD
Doxylamine—Nausea—Topiramate—migraine	4.75e-05	0.000726	CcSEcCtD
Doxylamine—CHRM1—Signaling by GPCR—HTR1D—migraine	4.73e-05	0.00209	CbGpPWpGaD
Doxylamine—Imipramine—SLC6A4—migraine	4.59e-05	0.0186	CrCbGaD
Doxylamine—HRH1—GPCR ligand binding—HTR7—migraine	4.56e-05	0.00202	CbGpPWpGaD
Doxylamine—Amitriptyline—SLC6A4—migraine	4.56e-05	0.0185	CrCbGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR7—migraine	4.55e-05	0.00201	CbGpPWpGaD
Doxylamine—Doxepin—HTR2A—migraine	4.53e-05	0.0183	CrCbGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2B—migraine	4.41e-05	0.00195	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2B—migraine	4.4e-05	0.00195	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.2e-05	0.00186	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.18e-05	0.00185	CbGpPWpGaD
Doxylamine—Promazine—HTR2A—migraine	4.03e-05	0.0163	CrCbGaD
Doxylamine—HRH1—Signaling Pathways—RAMP1—migraine	3.86e-05	0.00171	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CALCRL—migraine	3.86e-05	0.00171	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RAMP1—migraine	3.85e-05	0.0017	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CALCRL—migraine	3.85e-05	0.0017	CbGpPWpGaD
Doxylamine—Imipramine—HTR2A—migraine	3.52e-05	0.0143	CrCbGaD
Doxylamine—Amitriptyline—HTR2A—migraine	3.5e-05	0.0142	CrCbGaD
Doxylamine—HRH1—GPCR ligand binding—HTR2A—migraine	3.2e-05	0.00141	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR2A—migraine	3.19e-05	0.00141	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR1B—migraine	3.17e-05	0.0014	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR1B—migraine	3.16e-05	0.0014	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR1A—migraine	3.05e-05	0.00135	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR1A—migraine	3.04e-05	0.00134	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—TAC1—migraine	3e-05	0.00133	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—NPS—migraine	3e-05	0.00133	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—NPS—migraine	2.99e-05	0.00132	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—TAC1—migraine	2.99e-05	0.00132	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2C—migraine	2.95e-05	0.0013	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2C—migraine	2.94e-05	0.0013	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR1B—migraine	2.88e-05	0.00127	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR1B—migraine	2.87e-05	0.00127	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—EDNRA—migraine	2.86e-05	0.00127	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—EDNRA—migraine	2.86e-05	0.00126	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR1D—migraine	2.8e-05	0.00124	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR1D—migraine	2.8e-05	0.00124	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR1A—migraine	2.77e-05	0.00122	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR1A—migraine	2.76e-05	0.00122	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CALCA—migraine	2.76e-05	0.00122	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CALCA—migraine	2.75e-05	0.00122	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—NPS—migraine	2.73e-05	0.00121	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—TAC1—migraine	2.73e-05	0.00121	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—TAC1—migraine	2.72e-05	0.0012	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—NPS—migraine	2.72e-05	0.0012	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2C—migraine	2.67e-05	0.00118	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2C—migraine	2.67e-05	0.00118	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2B—migraine	2.61e-05	0.00115	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EDNRA—migraine	2.6e-05	0.00115	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2B—migraine	2.6e-05	0.00115	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EDNRA—migraine	2.59e-05	0.00115	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR7—migraine	2.58e-05	0.00114	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR7—migraine	2.57e-05	0.00114	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CALCA—migraine	2.5e-05	0.00111	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CALCA—migraine	2.5e-05	0.0011	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR7—migraine	2.34e-05	0.00104	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR7—migraine	2.33e-05	0.00103	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LRP1—migraine	2.3e-05	0.00102	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LRP1—migraine	2.29e-05	0.00101	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2A—migraine	1.81e-05	0.000799	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2A—migraine	1.8e-05	0.000796	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOTCH4—migraine	1.76e-05	0.000779	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOTCH4—migraine	1.76e-05	0.000776	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR1B—migraine	1.7e-05	0.000751	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR1B—migraine	1.69e-05	0.000749	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2A—migraine	1.64e-05	0.000725	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR1A—migraine	1.64e-05	0.000723	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2A—migraine	1.64e-05	0.000723	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR1A—migraine	1.63e-05	0.000721	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NPS—migraine	1.61e-05	0.000712	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PGR—migraine	1.61e-05	0.000712	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TAC1—migraine	1.61e-05	0.000712	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PGR—migraine	1.61e-05	0.00071	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TAC1—migraine	1.61e-05	0.00071	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NPS—migraine	1.61e-05	0.00071	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2C—migraine	1.58e-05	0.000699	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2C—migraine	1.57e-05	0.000696	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EDNRA—migraine	1.54e-05	0.00068	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EDNRA—migraine	1.53e-05	0.000677	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOTCH3—migraine	1.5e-05	0.000662	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOTCH3—migraine	1.49e-05	0.00066	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CALCA—migraine	1.48e-05	0.000654	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CALCA—migraine	1.47e-05	0.000652	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR7—migraine	1.38e-05	0.000612	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR7—migraine	1.38e-05	0.00061	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TGFBR2—migraine	1.19e-05	0.000527	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TGFBR2—migraine	1.19e-05	0.000525	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2A—migraine	9.69e-06	0.000429	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2A—migraine	9.66e-06	0.000427	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ESR1—migraine	8.6e-06	0.00038	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ESR1—migraine	8.57e-06	0.000379	CbGpPWpGaD
